Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3129 | Provision of flour Wiki | 1.00 |
| drug3105 | Promotion of flour Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D006402 | Hematologic Diseases NIH | 0.71 |
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
| D018352 | Coronavirus Infections NIH | 0.04 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0001871 | Abnormality of blood and blood-forming tissues HPO | 0.71 |
Navigate: Correlations HPO
There is one clinical trial.
This is an observational prospective cohort study to evaluate the clinical course and outcomes of COVID-19 and the underlying disease in patients with hematologic disease (malignant or non-malignant).
Description: Rate of death from any cause
Measure: 30-day all-cause mortality Time: 30 dayDescription: Rate of COVID-19 complications
Measure: COVID-19 complications Time: 30 dayDescription: Rate of ICU admission
Measure: ICU admission Time: 30 dayDescription: Rate of mechanical ventilation / O2 requirement
Measure: Mechanical ventilation / O2 requirement Time: 30 dayDescription: Rate of relapse or progression of hematologic disease
Measure: Relapse or progression of hematologic disease Time: 30 day, 90 day and 180 dayDescription: Number of patients alive
Measure: Overall survival Time: 30 day, 90 day and 180 dayDescription: Putative risk factors for the severity and lethality of COVID-19
Measure: Risk factors Time: 30 day, 90 day and 180 dayAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports